Please check your internet connection and try again.
# Ecospirin (Aspirin, Enteric-Coated)
## Overview
Ecospirin is an enteric-coated formulation of aspirin, a non-steroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and antiplatelet properties. The enteric coating delays release until the drug reaches the small intestine, reducing gastric irritation.
## Primary Indications
* **Cardiovascular prophylaxis:** Prevention of myocardial infarction, stroke, and other thrombotic events in patients with established cardiovascular disease or risk factors.
* **Pain and inflammation:** Management of mild to moderate pain and inflammatory conditions (less common for enteric-coated formulations due to slower onset compared to immediate-release).
## Adult Dosing
* **Cardiovascular prophylaxis:** Typically 75 mg to 162 mg once daily. Doses may vary based on specific indication and physician discretion.
## Pediatric Dosing
* Aspirin is generally **contraindicated in children and adolescents** due to the risk of Reye's syndrome, particularly during viral illnesses.
## Dose Adjustments
* No dose adjustments are typically required for renal or hepatic impairment, but caution is advised in severe dysfunction.
## Contraindications
* Known hypersensitivity to aspirin or other salicylates.
* Active peptic ulcer disease.
* Bleeding disorders (e.g., hemophilia, thrombocytopenia).
* Severe hepatic or renal impairment.
* Children and adolescents with viral infections (risk of Reye's syndrome).
* Third trimester of pregnancy.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, nausea, vomiting, abdominal pain, heartburn, gastrointestinal bleeding, ulceration.
* **Hematologic:** Increased bleeding risk, bruising, epistaxis, petechiae.
* **Hypersensitivity:** Bronchospasm (especially in aspirin-sensitive asthmatics), urticaria, angioedema.
* **Other:** Tinnitus (especially at higher doses), dizziness.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 inhibitors:** Additive GI toxicity and increased bleeding risk.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding, particularly in the GI tract.
* **Methotrexate:** Aspirin can increase methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Aspirin can interfere with the uricosuric effect.
## Monitoring
* **Signs and symptoms of GI bleeding:** Melena, hematemesis, abdominal pain.
* **Signs and symptoms of excessive bleeding:** Easy bruising, prolonged bleeding from cuts, epistaxis.
* **Renal function:** Particularly in patients with pre-existing renal disease or those on concurrent nephrotoxic agents.
* **Tinnitus:** May indicate therapeutic drug levels are being approached or exceeded, especially with higher doses.
## Clinical Pearls
* The enteric coating is designed to be swallowed whole and **should not be crushed, chewed, or broken** to maintain its protective effect.
* For acute pain or fever, immediate-release aspirin formulations are preferred due to faster absorption.
* Discontinue aspirin at least 5-7 days before elective surgery, if feasible, due to its irreversible antiplatelet effect.
**Disclaimer:** This information is for educational purposes and does not substitute professional medical advice. Always consult the most current prescribing information and your healthcare provider for any health concerns or before making any decisions related to your health or treatment.
